Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

Research output: Contribution to journalLetterResearchpeer-review

Morten Orebo Holmström, Guy W. Novotny, Jesper Petersen, Mia Aaboe-Jørgensen, Hans Carl Hasselbalch, Mads H. Andersen, Signe Ledou Nielsen, Daniel El Fassi, Claudia Schöllkopf

Original languageEnglish
JournalLeukemia and Lymphoma
Publication statusE-pub ahead of print - 2019

ID: 226877207